Fringe proteins and notch signalling
CA 2268751 A1 · Owner: Egan, Sean E. · Inventors: Egan, Sean E.; Phillips, Robert A.; Cohen, Brenda L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Three mammalian Fringe cDNAs have been cloned and sequenced and their , interaction with the Notch receptor signalling pathway has been described. Methods are provided for preventing or treating disorders characterised by an abnormality in Notch receptor signalling.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 20, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 20, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 20, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.